Headquarters: United States
Industry: Early Drug Development
Investors Number: 7.0
Funding Status: Early Stage Venture
Last Funding Type: Series A
Founded Date: 2020-01-01
Total Funding: 37200000.0
Last Funding Date: 2022-06-08